The US Food and Drug Administration (FDA) has accepted Sobi North America’s avatrombopag (DOPTELET) supplemental new drug application (sNDA) to treat paediatric immune thrombocytopenia. The therapy is …
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=675cef97f9164c5aa9777c1fc09b3a80&url=https%3A%2F%2Fwww.msn.com%2Fen-us%2Fmoney%2Fgeneral%2Ffda-accepts-sobi-north-america-s-thrombocytopenia-therapy-snda%2Far-AA1vPl5C&c=2712873759957520723&mkt=en-us
Author :
Publish date : 2024-12-13 02:31:28
Copyright for syndicated content belongs to the linked Source.